News

• AstraZeneca, Samsung Biologics shut down joint venture - report
  05/24/2022 / 07:05 - TeleTrader
•  
• AstraZeneca's Q1 core EPS rises 16% to $1.89
  04/29/2022 / 08:06 - TeleTrader
•  
• Canada approves AstraZeneca's Evusheld
  04/14/2022 / 17:37 - TeleTrader
•  
• EMA backs AstraZeneca's COVID drug for prevention
  03/24/2022 / 17:44 - TeleTrader
•  
• AstraZeneca may give up seeking US jab approval
  03/17/2022 / 17:08 - TeleTrader
•  
• HUTCHMED Receives a US$15 million Milestone from AstraZeneca for Initiating Start-up Activities for a Global Phase III Study of ORPATHYS® in Lung Cancer
  03/07/2022 / 05:30 - GlobeNewswire
•  
• HUTCHMED Reports 2021 Full Year Results and Provides Business Updates
  03/03/2022 / 13:00 - GlobeNewswire
•  
• Nirsevimab significantly protected infants against RSV disease in Phase 3 trial
  03/03/2022 / 08:00 - GlobeNewswire
•  
• AstraZeneca PLC – ADR to Join the NASDAQ-100 Index Beginning February 22, 2022
  02/10/2022 / 23:00 - GlobeNewswire
•  
• AstraZeneca's Q4 revenue soars 62% to $12.01B
  02/10/2022 / 08:09 - TeleTrader
•  
• AstraZeneca's Vaxzevria boosts response against Omicron - study
  01/13/2022 / 10:05 - TeleTrader
•  
• Covis Completes Acquisition of Global Respiratory Portfolio of Two Medicines from AstraZeneca
  01/05/2022 / 08:30 - GlobeNewswire
•  
• Ovid Therapeutics Expands Epilepsy Franchise with Novel KCC2 Activators
  01/03/2022 / 12:30 - GlobeNewswire
•  
• Israel changes advice on booster timeline
  12/27/2021 / 16:49 - TeleTrader
•  
• AZ booster ups antibody levels against Omicron
  12/23/2021 / 08:39 - TeleTrader